C07K 14/4711
Alzheimer's disease
Official title: {Alzheimer's disease; Amyloid plaque core protein}
C07K14/4711 (Alzheimer's disease) appears on 827 US grants and 1,257 published applications in this corpus.
Search patents in C07K- Granted patents
- 827
- Published applications
- 1,257
- Assignees
- 618
- Inventors
- 2,264
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 7 | 0 |
| 1994 | 2 | 0 |
| 1995 | 8 | 0 |
| 1996 | 14 | 0 |
| 1997 | 17 | 0 |
| 1998 | 37 | 0 |
| 1999 | 29 | 0 |
| 2000 | 18 | 0 |
| 2001 | 34 | 14 |
| 2002 | 23 | 77 |
| 2003 | 21 | 86 |
| 2004 | 42 | 78 |
| 2005 | 35 | 84 |
| 2006 | 38 | 48 |
| 2007 | 26 | 46 |
| 2008 | 23 | 51 |
| 2009 | 27 | 45 |
| 2010 | 31 | 47 |
| 2011 | 21 | 52 |
| 2012 | 22 | 38 |
| 2013 | 21 | 39 |
| 2014 | 32 | 33 |
| 2015 | 33 | 42 |
| 2016 | 24 | 47 |
| 2017 | 32 | 37 |
| 2018 | 27 | 51 |
| 2019 | 25 | 42 |
| 2020 | 22 | 36 |
| 2021 | 26 | 52 |
| 2022 | 22 | 48 |
| 2023 | 19 | 54 |
| 2024 | 25 | 28 |
| 2025 | 21 | 52 |
| 2026 | 19 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Tau-binding antibodies29 Sep 2026US 12,747,288 B2Ucb Biopharma Srl
- Self-assembled peptide nanorods and uses thereof15 Sep 2026US 12,735,458 B2DéVeloppement Mondial Nanotech Inc.
- Treating Alzheimer's disease1 Sep 2026US 12,723,064 B2Ramot at Tel-Aviv University Ltd.
- Tau epitope and binding molecules25 Aug 2026US 12,715,908 B2Gen2 Neuroscience Limited
- Self-assembling systems for modeling intracellular protein aggregation10 Sep 2026US 2026/0265322 A1
- Inhibitory Peptides for the Diagnostic and/or Treatment of Tauopathies27 Aug 2026US 2026/0248877 A1École des Hautes Études en Santé Publique
- Aav vector and use thereof27 Aug 2026US 2026/0248967 A1Prodegre Therapeutics (Shangha) Co., Ltd.
- Proteins and protein libraries13 Aug 2026US 2026/0234206 A1
- Tau and amyloid beta peptide immunogen compositions and related methods6 Aug 2026US 2026/0224676 A1Vaxxinity, Inc.
Most cited
By later US patents
- Technique for extracorporeal treatment of blood460US 5,910,252 ACobe Laboratories, Inc. · 1999
- Polypeptide marker for Alzheimer's disease and its use for diagnosis318US 4,666,829 AUniversity of California · 1987
- Methods for the detection of soluble .beta.-amyloid peptide244US 5,593,846 AAthena Neurosciences, Inc. · 1997
- Automatic priming technique208US 5,776,345 ACobe Laboratories, Inc. · 1998
- Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease201US 5,387,742 AScios Nova Inc. · 1995